Haploidentical hematopoietic stem cell transplantation with one-day posttransplant cyclophosphamide and anti-thymocyte globulin for graft failure

Patients with myelofibrosis usually have poor prognosis. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the only curative therapy, which has graft failure as a life-threatening complication. However, no consensus is available with regard to therapeutic options for patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Imanaga, Hiroshi, Ohta, Takanori, Oku, Seido, Sugio, Yasuhiro, Ohno, Yuju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia-Pacific Blood and Marrow Transplantation Group 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261719/
https://www.ncbi.nlm.nih.gov/pubmed/37325246
http://dx.doi.org/10.31547/bct-2019-009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261719/
https://www.ncbi.nlm.nih.gov/pubmed/37325246
http://dx.doi.org/10.31547/bct-2019-009

Ejemplares similares